BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2170478)

  • 1. European experience with itraconazole in systemic mycoses.
    Viviani MA; Tortorano AM; Pagano A; Vigevani GM; Gubertini G; Cristina S; Assaisso ML; Suter F; Farina C; Minetti B
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):587-93. PubMed ID: 2170478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with itraconazole in deep mycoses in northern Italy.
    Viviani MA; Tortorano AM; Woenstenborghs R; Cauwenbergh G
    Mykosen; 1987 May; 30(5):233-44. PubMed ID: 3039366
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
    Denning DW; Tucker RM; Hanson LH; Stevens DA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):602-7. PubMed ID: 2170480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with itraconazole in cryptococcosis and aspergillosis.
    Viviani MA; Tortorano AM; Langer M; Almaviva M; Negri C; Cristina S; Scoccia S; De Maria R; Fiocchi R; Ferrazzi P
    J Infect; 1989 Mar; 18(2):151-65. PubMed ID: 2540243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole therapy in aspergillosis: study in 49 patients.
    Dupont B
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):607-14. PubMed ID: 2170481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
    Odds FC
    J Dermatol Sci; 1993 Apr; 5(2):65-72. PubMed ID: 8395201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Itraconazole in the treatment of deep mycoses].
    Viviani MA; Tortorano AM
    Ann Ist Super Sanita; 1987; 23(4):873-7. PubMed ID: 2837939
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results.
    Phillips P; Fetchick R; Weisman I; Foshee S; Graybill JR
    Rev Infect Dis; 1987; 9 Suppl 1():S87-93. PubMed ID: 3027852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole in the treatment of human mycoses: review of three years of clinical experience.
    Cauwenbergh G; De Doncker P; Stoops K; De Dier AM; Goyvaerts H; Schuermans V
    Rev Infect Dis; 1987; 9 Suppl 1():S146-52. PubMed ID: 3027842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.